Last reviewed · How we verify
NCT06857331
Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients
NA trial testing Erector Spinae Plane Block using 0.2% ropivacaine in Liver Transplant in 50 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | Bogomolets National Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 5 May 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 10 December 2025 |
| Sites | 1 location across Ukraine |
Drugs / interventions tested
- Erector Spinae Plane Block using 0.2% ropivacaine — full drug profile →
Conditions studied
- Liver Transplant — all drugs for Liver Transplant →
- Erector Spina Plan Block — all drugs for Erector Spina Plan Block →
Sponsor
Bogomolets National Medical University
Who can join
Eligibility, any sex, with Liver Transplant or Erector Spina Plan Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06857331
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Erector Spinae Plane Block using 0.2% ropivacaine
Trials testing the same drug.
- NCT06087549 — PENG Block vs. ESP Block for Pediatric Hip Surgery · Phase 4 · completed
Other recruiting trials for Liver Transplant
Currently open trials in the same condition.
- NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
- NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
- NCT07216508 — Liver Transplant CGM · recruiting
- NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
- NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting
Other Bogomolets National Medical University trials
Trials by the same sponsor.
- NCT07249814 — Comparison of Fractionated Versus Bolus Administration of Different Doses of Hyperbaric Bupivacaine Combined With Opioid · NA · completed
- NCT05804422 — Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study) · NA · completed
- NCT06352697 — Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults MASLD Patients (DELI_MASLD Study) · NA · completed
- NCT05770076 — Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study) · NA · completed
- NCT06619977 — ANI-Guided Fentanyl Infusion During Living Donor Liver Resections · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06857331 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bogomolets National Medical University
- Last refreshed: 4 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06857331.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing